methyl (S)-cyclohex-3-ene-1-carboxylate, 98%, 25g

1-[(4-Methylphenyl)sulfonyl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile, 98%, 250mg

(S)-3-amino-4-(4-nitrophenyl)butanoic acid hydrochloride, 98+%, 100mg

2-(2,3-Dimethylphenyl)acetic acid, 95.0%, 250mg

5-Chloro-3-methylbenzo[d]oxazol-2(3H)-one, 97%, 5g

2-(2-Chloroacetamido)-N-(4-chlorophenyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide, 97%, 100mg

3-(4-Methoxy-phenyl)-4,5-dihydro-isoxazole-5-carboxylic acid, 95.0%, 2g

n-(3-Aminopropyl)-N-methylmethanesulfonamide, 95%, 500mg

2-Furoyltrifluoroacetone25g

2,4,6-Trimethyl-benzenesulfonate1-amino-pyrazin-1-ium, 95.0%, 1g

Solution étalon ICP de chrome, 500 mL, 10 000 mg/L Cr, HDPE

4-(Azetidin-3-yl)thiomorpholine 1,1-dioxide dihydrochloride, 95.0%, 5g

N-(tert-Butoxycarbonyl)-D-leucine Monohydrate>98.0%(T)25g